Replies to post #32640 on Relief Therapeutics Holding AG (RLFTF)

[J-Belfort]

Because the trial is for 165 patients, makes sense to do a read of 165 EAP patients as well for comparative purposes. I'd also assume we will see comparative results of 90 EAP vs either 90 non placebo or 90 placebo. Maybe your right, maybe we will see data on 137,161,168 ... We will see more data soon though

I do disagree that a data release would be viewed as a "pump before poor trial results". Showing great results in patients too sick for your trial is only good news. Imagine what the trial results will be like!!!

Best,
JB